One award available.
Brown Rudnick will provide a one-full day (up to 8 hrs.) intellectual property strategy session for a company. Brown Rudnick will first review company background materials (e.g., investor presentations, technical documents, existing intellectual property, etc.). Brown Rudnick will then host an intellectual property strategy session for the company with a team from the firm that includes at least one partner. The session will focus on creating a general plan for development and implementation of the company’s patent portfolio. The goal of the session will be to lay-out a plan to create a dominant position with respect to the company’s proprietary products. The session will also focus on how to create commercial barriers-to-entry against competitors. Brown Rudnick will provide a written summary of the session.
Brown Rudnick’s Global Life Sciences Group consists of a dedicated team of professionals focused on helping life sciences companies across the world. We also work closely with management teams, lenders, and investors active in the life sciences sector. Our clients span the life sciences spectrum, including pharmaceutical, medical device, diagnostic, biotechnology, biopharmaceutical, biomedical, and nutraceutical.
Our multi-disciplinary team includes lawyers who were former executives and in-house counsel in life sciences companies and have significant first-hand experience with the business and legal issues facing clients in this sector. Clients trust us to provide practical advice that is based on a deep foundation of experience and understanding of the life sciences sector and the challenges confronting companies at every stage of the business life cycle.
We help companies around the world turn good science into good business. Our global representation includes advising clients in major life sciences markets in North America and Western Europe, as well as emerging markets in Central and Eastern Europe, Africa, the Middle East, South America and Central and Eastern Asia.
Our clients range from start-ups to established, multi-national public companies, as well as those who invest in such companies. Our deep relationships with both companies and investors make us uniquely situated to bring together businesses that need financing with funding sources who are a good match, taking into account the company’s vertical space, its stage of development and management team. With these close industry connections, we also help bring together companies looking for an exit with potential acquirers. With our knowledge and experience, our life sciences team delivers results and helps clients move to the next level. We care as much about your business as you do.